跳至主要内容
临床试验/NCT03920085
NCT03920085已完成不适用

Clinical Evaluation of LifeScan Blood Glucose Monitoring Systems

LifeScan Scotland Ltd1 个研究点 分布在 1 个国家目标入组 123 人开始时间: 2019年1月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
123
试验地点
1
主要终点
Clinical Evaluation of Blood Glucose result (mg/dl) from LifeScan Blood Glucose Monitoring Systems by comparison of a blood glucose result (mg/dl) obtained from a reference instrument (YSI2900) to demonstrate accuracy (%).

研究概览

简要总结

Study to determine the performance of the LifeScan BGMS when conducted at MAC clinical site.

详细描述

This study will evaluate the performance of the MAC clinical site to evaluate accuracy performance of LifeScan blood glucose monitoring systems as it is conducted at other LifeScan UK affiliated clinic sites. Multiple LifeScan Blood Glucose Monitoring System (BGMS) will be tested with production lots which have passed release testing.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must be enrolled in LifeScan Patient Registry.
  • Participants must have read the Information sheet and signed an informedconsent form >prior to study participation.
  • Participants must be 16 years or older.
  • Participants must be diagnosed with Diabetes

排除标准

  • > Participants not enrolled in the LifeScan Patient Registry

结局指标

主要结局

Clinical Evaluation of Blood Glucose result (mg/dl) from LifeScan Blood Glucose Monitoring Systems by comparison of a blood glucose result (mg/dl) obtained from a reference instrument (YSI2900) to demonstrate accuracy (%).

时间窗: Less than 30 minutes

Clinical Evaluation of Blood Glucose result (mg/dl) from LifeScan Blood Glucose Monitoring Systems by comparison of a blood glucose result (mg/dl) obtained from a reference instrument (YSI2900) to demonstrate accuracy (%).

次要结局

未报告次要终点

研究者

发起方
LifeScan Scotland Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验